ISICEM: Albumin does not improve survival in sepsis

March 19, 2014
ISICEM: albumin does not improve survival in sepsis

(HealthDay)—For patients with severe sepsis in intensive care units, the use of albumin replacement in addition to crystalloid solution does not improve survival, according to a study published online March 18 in the New England Journal of Medicine. This research was published to coincide with the International Symposium on Intensive Care and Emergency Medicine, held from March 18 to 21 in Brussels.

Pietro Caironi, M.D., Ph.D., from the Università degli Studi di Milano, and colleagues randomized 1,818 patients with in 100 units to receive 20 percent albumin and crystalloid solution or crystalloid solution alone.

The researchers found that, compared with those in the crystalloid group, patients in the albumin group had a higher mean arterial pressure (P = 0.03) and lower net fluid balance (P < 0.001) during the first seven days. There was no significant between-group difference in the total daily amount of administered fluid (P = 0.10). At 28 days, 31.8 percent of the albumin group and 32.0 percent of the crystalloid group had died (relative risk in albumin group, 1.00; P = 0.94). Mortality at 90 days was 41.1 and 43.6 percent, respectively (relative risk, 0.94; P = 0.29).

"In with severe sepsis, albumin replacement in addition to crystalloids, as compared with crystalloids alone, did not improve the rate of survival at 28 and 90 days," the authors write.

The study was funded by the Italian Medicines Agency.

Explore further: ISICEM: Septic shock death equal with high, low BP target

More information: Abstract
Full Text
More Information

Related Stories

ISICEM: Septic shock death equal with high, low BP target

March 19, 2014

(HealthDay)—For patients with septic shock undergoing resuscitation, 28- and 90-day mortality is not significantly different with high- or low-target arterial pressure. This research was published online March 18 in the ...

Albumin improves bacterial peritonitis outcomes

February 7, 2013

(HealthDay)—For patients with spontaneous bacterial peritonitis (SBP), albumin infusion is associated with reduced renal impairment and decreased mortality, according to research published in the February issue of Clinical ...

Ringer's acetate better for patients with severe sepsis

June 28, 2012

(HealthDay) -- Fluid resuscitation with hydroxyethyl starch (HES) 130/0.4 for patients with severe sepsis leads to an increased risk of death at day 90 and an increased likelihood of requiring renal-replacement therapy, compared ...

Recommended for you

Raising the curtain on cerebral malaria's deadly agents

December 6, 2016

Using state-of-the-art brain imaging technology, scientists at the National Institutes of Health filmed what happens in the brains of mice that developed cerebral malaria (CM). The results, published in PLOS Pathogens, reveal ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.